Darwin Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.99 M
as on 11-12-2024
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.75 Cr
as on 11-12-2024
- Revenue 4.53%
(FY 2023)
- Profit 9.65%
(FY 2023)
- Ebitda 36.38%
(FY 2023)
- Net Worth 12.38%
(FY 2023)
- Total Assets -27.02%
(FY 2023)
About Darwin Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M.
The company currently has active open charges totaling ₹2.75 Cr.
Lakshmanareddy Dontireddy, Prvdhvi Donthireddy, and Venkata Donthireddy serve as directors at the Company.
- CIN/LLPIN
U24239TG1995PTC019481
- Company No.
019481
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationNa, Telangana
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Darwin Formulations Private Limited offer?
Darwin Formulations Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Pharmaceutical Tablets, Respiratory System Drugs, Anti Asthma Drug, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules.
Who are the key members and board of directors at Darwin Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmanareddy Dontireddy  | Managing Director | 17-Feb-1995 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prvdhvi Donthireddy | Director | 01-Apr-2013 | Current |
| Venkata Donthireddy | Director | 21-Mar-1998 | Current |
Financial Performance of Darwin Formulations.
Darwin Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.53% increase. The company also saw a slight improvement in profitability, with a 9.65% increase in profit. The company's net worth Soared by an impressive increase of 12.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Darwin Formulations?
In 2023, Darwin Formulations had a public holding of 13.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Loony Bin Technologies Private LimitedActive 12 years 10 months
Lakshmanareddy Dontireddy is a mutual person
- Udbhav Metal Systems Manufacturing Private LimitedActive 7 years 1 month
Prvdhvi Donthireddy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Apr 2021 | ₹2.01 M | Open |
Kotak Mahindra Bank Limited Creation Date: 25 Feb 2014 | ₹1.75 Cr | Open |
Indian Overseas Bank Creation Date: 18 Dec 2009 | ₹2.50 M | Open |
How Many Employees Work at Darwin Formulations?
Darwin Formulations has a workforce of 19 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Darwin Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darwin Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
